Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Ранг среди акций #26679
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Цена акции
$3.49
Последняя синхронизация: 2023-12-19
Рыночная капитализация
$38.68M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Neoleukin Therapeutics, Inc. (NLTX)

Категория

История цены акций Neoleukin Therapeutics, Inc. (NLTX)
Наивысшая цена закрытия: $3.45 2023-12-01

Наименьшая цена закрытия: $64.26 2014-03-01
История цены акций Neoleukin Therapeutics, Inc. с 2014 по 2026
Годовая динамика цены акций
Год Результативность
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$171.67 -
DE
$163.27 25.50%
DE
$38.00 22.72%
JP
$220.77 33.35%
CH
$21.01 11.96%
IN